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Title of review 
Cardiac testing for coronary artery disease in potential kidney transplant recipients 
What is this review about? 
Screening for coronary artery disease is an important part of pre-transplant assessment for kidney 
transplant candidates. We investigated the accuracy of non-invasive cardiac screening tests compared 
with coronary angiography to detect coronary artery disease in potential kidney transplant recipients. 
What are the findings? 
Dobutamine stress echocardiography [pooled sensitivity 0.79, 95% CI 0.67 to 0.88, pooled specificity 
0.89, 95% CI 0.81 to 0.94] and myocardial perfusion scintigraphy [pooled sensitivity 0.74, 95% CI 0.54 to 
0.87, pooled specificity 0.70, 95% CI 0.51 to 0.84] had moderate sensitivity and specificity in detecting 
coronary artery disease. There was evidence that Dobutamine stress echocardiography had improved 
accuracy over myocardial perfusion scintigraphy (P = 0.02) when all studies were included in the analysis, 
but this was not significant when we excluded studies of poorer methodological quality, or which 
defined significant coronary disease using a higher threshold of  ≥70% stenosis (P = 0.09).   
What are the findings based on? 
This was a systematic review of diagnostic accuracy, and included meta-analysis using data from 13 
dobutamine stress echocardiography studies (745 participants) and nine myocardial perfusion 
scintigraphy studies (582 participants). It also included three echocardiography studies, two exercise 
stress electrocardiography studies, three resting electrocardiography studies and one study each of 
electron beam computed tomography, exercise ventriculography, carotid intimal media thickness and 
digital subtraction fluorography. We used a hierarchical modelling strategy to produce summary 
receiver operating characteristic curves, and pooled estimates of sensitivity and specificity.  
Implications for practice 
Both tests, especially dobutamine stress echocardiography, have a role as triage tests for intermediate 
risk transplant candidates, with negative results precluding the need for further evaluation with 
coronary angiography, thereby avoiding unnecessary risk to patients and potentially reducing healthcare 
costs. The true discriminating value of both tests (especially dobutamine stress echocardiography) is in 
detecting coronary artery disease in intermediate risk patients - a category that includes many potential 
kidney transplant recipients. Both tests help to stratify patients at intermediate risk into either high or 
low risk categories. When dobutamine stress echocardiography was used, patients at intermediate risk 
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of coronary artery disease who tested positive had post-test probability of 73% to 90% (high risk) and 
those who tested negative were downgraded to low risk (10% to 27%).  
Clinical perspective 
 
Physicians assessing potential kidney transplant recipients often face the dilemma of choosing which 
type of non invasive stress testing to use. Both non invasive tests have only moderate sensitivity and 
specificity. Coronary angiography, however, is invasive, and for those patients not yet on haemodialysis, 
exposure to intra-arterial contrast poses considerable risk of worsening renal function. Non invasive 
diagnostic imaging has evolved in the past decade. Myocardial perfusion scintigraphy has seen advances 
in both stress agent and radioactive perfusion tracer, both of which may have resulted in improvements 
in diagnostic accuracy. Dobutamine stress echocardiography has also matured as an imaging modality. 
Use of other imaging modalities, such as CT coronary angiography and cardiac MRI, has also become 
more widespread, but there are significant barriers to implementation in the chronic kidney disease 
patient population. Current evidence suggests that, where feasible, dobutamine stress 
echocardiography should be used as the screening investigation of choice over myocardial perfusion 
scintigraphy. Myocardial perfusion scintigraphy and dobutamine stress echocardiography may also 
provide additional prognostic information, which will be the focus of a future review. 
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Figure: Post-test probabilities for significant coronary artery disease in potential kidney transplant 
recipients. †Based on the positive and negative likelihood ratios calculated from the systematic review in 
studies which avoided partial verification and used a reference standard threshold of ≥70% stenosis. DSE 
had a positive likelihood ratio of 6.44 (95% CI 3.03 to 13.70) and negative likelihood ratio of 0.26 (95% CI 
0.13 to 0.50). MPS had a positive likelihood ratio of 2.89 (95% CI 1.39 to 5.99) and negative likelihood 
ratio of 0.43 (95% CI 0.23 to 0.80). 
 
